Tristel Share Discussion Threads

[piedro] 12/9/2019 11:31

Tristel Global@TristelGlobal
We are excited to be part of the 5th International
Conference on Prevention & Infection Control in
Geneva, Switzerland!

Come and visit us at booth 31 to know more
about our high-level & sporicidal disinfectants!

[piedro] 05/9/2019 09:55

04 September 2019
By Maynard Paton
Tristel: 2019 Open Day Yields No Revelations Although Encouraging Sales Developments Have Emerged In The UK, France And Italy

[james188] 27/8/2019 15:35

I agree with the general observation and sentiment, but I believe that TSTL no longer use ED and stick to finncap. In any event, there has been takeover speculation about TSTL for yonks and Ecolab have been mentioned before.Nothing new.

[piedro] 27/8/2019 15:05

FWIW,

Here is the link:



... it's what they get paid for.

[equitydev] 27/8/2019 12:33

Tristel highlighted (page 4) as a potential acquisition target in today's M&A related research report - UK plc ‘going for a song’.

hxxps://www.equitydevelopment.co.uk/2019/08/27/uk-plc-going-for-a-song/

[piedro] 27/8/2019 08:48

FYI,

Candida auris: The new superbug on the block
By Lena Ciric
BBC News
17 August 2019
... C. auris is very tough and can survive on surfaces for a long time.
It also cannot be killed using most common detergents and disinfectants.
Using the right cleaning chemicals is important to eliminate it from hospitals, especially if there is an outbreak.

[piedro] 20/8/2019 06:52

An interesting product ...

New Febreze Professional Kills 99.9% of Bacteria on 'Un-Washable' Soft Surfaces While Eliminating Odors with Fresh Scent of FebrezeAugust 20, 2019

[best1467] 07/8/2019 18:17

It’s a no then on the board

[piedro] 05/8/2019 12:19

page 7 of the presentation ...

Medical devices {Clo2} ... £20.5m
Other ClO2 ............... £ 2.2m
Non ClO2 ................. £ 3.3m

- I was surprised to find that the 'Other ClO2' which includes 'Surfaces' contributes such a small proportion of the revenue
- will 'cache' catch on ?

[piedro] 05/8/2019 12:01

New look ...



"Cache is a product range dedicated entirely to hospital surface disinfection.



- less colourful for the 'cleaners'

[piedro] 05/8/2019 11:52

New product .... ?



Tristel Duo NCU

AVAILABLE EXCLUSIVELY IN AUSTRALIA AND NEW ZEALAND

The joint ACIPC and ASUM Guidelines for Disinfection of Ultrasound Transducers1 highlight that use of skin surface transducers in these areas may require a higher level of disinfection. With cleaning not equating to appropriate disinfection; low-level disinfection covering only a limited range of microorganisms and high-level disinfection being impractical or time-consuming, intermediate-level disinfection provides the answer.

Microbiological Efficacy
Tristel Duo NCU is effective in 30 seconds against microorganisms of concern, including:
- Human Papillomavirus (HPV)
- Herpes Simplex Virus Type 1
- Candida albicans
- Staphylococcus aureus
- Pseudomonas aeurginosa

[best1467] 02/8/2019 06:47

Any new on the USA development or lack of and the Israeli investment with the mobile attachment

[piedro] 31/7/2019 17:03

Francisco Soler now reduced his holdings to 12.82%

I notice from the Presentation {p.23} that there is an Elanor Dixon for 'Surfaces' - presumably not related to the Financial Director !!

on LinkedIn her title is 'Head of Product Management'

[dozey3] 31/7/2019 13:34

Yes, my seat was empty this year but if any gems appeared I would be grateful to hear.

[piedro] 31/7/2019 08:00

The Shareholder Open Day presentation is available on the website

[piedro] 31/7/2019 07:46

Another successful Open Day at @TristelGlobal’s (AIM: #TSTL) HQ for investors




- and some empty seats

[melton john] 22/7/2019 07:57

Still no FDA approval. USA seem very protectionist these days. In-line result without this news that were waiting for is frustrating.

[metis20] 22/7/2019 07:50

The Company confirms that results will be in line with market expectations and it expects to report turnover of £26m (2018: £22.2m), with pre-tax profit (before share-based payments) of at least £5.5m (2018: £4.7m). Revenue from overseas markets increased by 26% and contributed 55% of total revenues - a record level (2018: 51%). Revenue in the UK rose by 9%. Sales of products using the Company's core chlorine dioxide technology grew by 22% compared to non-core products which decreased by 5%.

Tristel has continued to generate significant levels of cash and at 30 June 2019 cash balances were £4.2m (30 June 2018: £6.7m). During the year the Company spent £4.9m to satisfy the cash element of the acquisition of its three distributors in Western Europe which demonstrates the cash generative nature of Tristel's core business.

[metis20] 11/7/2019 20:10

From last year's trading update 13 July -

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, provides a trading update for the year ended 30 June 2018 in advance of the Shareholder Open Day to be held at its headquarters in Snailwell, Cambridgeshire on Tuesday 17 July.

[valustar1] 10/7/2019 22:12

Will it not be day of the open day. 23 july

[metis20] 10/7/2019 10:41

FY Trading update imminent? Previous FY trading updates were -

2018 13 July

2017 19 July

2016 21 July

Interesting to see impact of weak pound and move into China and South Korea

[piedro] 28/6/2019 11:41

ACCC loses flushable wipes case as Federal Court rules they pose 'insignificant' risk
By Jamie McKinne



:-)

[zipstuck] 21/6/2019 10:25

AMS reports Brexit stock level issues

[zipstuck] 20/6/2019 09:07

NHS spending not helping with reduced ops but still holding.